# A Study of the Interaction of TAK-279 With Substances That Have an Impact on Metabolism in Healthy Adults

> **NCT05995249** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 172 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** TAK-279
- **DRUG:** Erythromycin
- **DRUG:** Phenytoin
- **DRUG:** Efavirenz

## Key facts

- **NCT ID:** NCT05995249
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-11
- **Primary completion:** 2023-12-18
- **Final completion:** 2023-12-31
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2024-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05995249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05995249, "A Study of the Interaction of TAK-279 With Substances That Have an Impact on Metabolism in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05995249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*